The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review

G. Garside, A. Round, K. Dalziel, K. Stein, Pamela Lee Royle

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-162
Number of pages161
JournalHealth Technology Assessment
Volume6
Issue number33
Publication statusPublished - 2002

Cite this

Garside, G., Round, A., Dalziel, K., Stein, K., & Royle, P. L. (2002). The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review. Health Technology Assessment, 6(33), 1-162.

The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review. / Garside, G.; Round, A.; Dalziel, K.; Stein, K.; Royle, Pamela Lee.

In: Health Technology Assessment, Vol. 6, No. 33, 2002, p. 1-162.

Research output: Contribution to journalArticle

Garside, G, Round, A, Dalziel, K, Stein, K & Royle, PL 2002, 'The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review', Health Technology Assessment, vol. 6, no. 33, pp. 1-162.
Garside, G. ; Round, A. ; Dalziel, K. ; Stein, K. ; Royle, Pamela Lee. / The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review. In: Health Technology Assessment. 2002 ; Vol. 6, No. 33. pp. 1-162.
@article{34f8b7f773e14cb0922b100405d5be22,
title = "The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review",
author = "G. Garside and A. Round and K. Dalziel and K. Stein and Royle, {Pamela Lee}",
year = "2002",
language = "English",
volume = "6",
pages = "1--162",
journal = "Health Technology Assessment",
issn = "1366-5278",
publisher = "National Co-ordinating Centre for HTA",
number = "33",

}

TY - JOUR

T1 - The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review

AU - Garside, G.

AU - Round, A.

AU - Dalziel, K.

AU - Stein, K.

AU - Royle, Pamela Lee

PY - 2002

Y1 - 2002

M3 - Article

VL - 6

SP - 1

EP - 162

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 33

ER -